Salt CompositionYou Searched
Unigrilin 20mg Injection
United Biotech Pvt. Ltd.
₹2,894
WHO GMP
Certified
Long Expiry
(>8 Months)
WHO GMP
Certified
Long Expiry
(>8 Months)
Used In
Prevention of Blood clots / Prevention of Heart attack
Customers also bought
More About Unigrilin
Benefits
In Prevention of Blood clots Unigrilin 20mg Injection prevents new blood clots from forming and prevents the existing ones from getting bigger. It works by blocking a substance in the body which is involved in blood clotting. Thus it helps your blood flow smoothly throughout the body. This can help reduce damage caused by clots in your lungs (pulmonary embolism), brain (stroke), heart (heart attack) or other blood vessels (thrombosis). In Prevention of Heart attack It prevents blood from clotting inside the veins and arteries. This helps the blood flow freely around your body thereby preventing a heart attack or stroke (or deep vein thrombosis or pulmonary embolism). Follow your doctor?s instructions carefully and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
Unigrilin 20mg Injection is an antiplatelet medication. It works by preventing the platelets from sticking together, thereby decreasing the formation of harmful blood clots.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Unigrilin 20mg Injection . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Safe when prescribed by an expert: Unigrilin 20mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Caution Advised: Unigrilin 20mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
NOT RELEVANT - Not relevant, as Unigrilin 20mg Injection is intended for use in hospitalised patients.
Caution Advised: Unigrilin 20mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Unigrilin 20mg Injection may be needed. Doctor consultation is advised. Use of Unigrilin 20mg Injection is not recommended in patients with severe kidney disease.
Seek medical advice from your doctor: There is limited information available on the use of Unigrilin 20mg Injection in patients with liver disease. Doctor consultation is advised. Use of Unigrilin 20mg Injection is not recommended in patients with severe liver disease.
What if I forget to take it?
If a dose of Unigrilin 20mg Injection is missed, it's advisable to consult your doctor.
Manufacturer Address
FC/B-1 (Extn.), Mohan Co-operative Industrial Estate Mathura Road, New Delhi - 110 044
References
Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 871
Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 355-56
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 485-46
Eptifibatide. Ferentino, Italy: Patheon Italia S.p.A.; 1998 (18 Mar. 2019)
Drugs.com. Eptifibatide Pregnancy and Breastfeeding Warnings (18 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO). Eptifibatide (18 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
